Healthcare has become digitized with telehealth and remote monitoring, EHRs and e-prescription and mobile health and wearable ...

Rather than bribing and wheedling physicians to pretty-please-prescribe-our-drug, websites allow companies to deal drugs ...

The rise of artificial intelligence (AI), digitalisation, wider adoption of tools for marketing automation, and numerous other technologies have significantly reshaped the world of pharma for the ...

Digital marketing still dominates for pharma marketers Tag recently conducted an online survey of pharma marketers across Europe and the US asking them which marketing channels and techniques are ...

About AVT23 AVT23 is a monoclonal antibody and proposed biosimilar to Xolair ® (omalizumab). AVT23 is an investigational compound and has not received regulatory approval in any country. Biosimilarity ...

In a report released today, Douglas Tsao from H.C. Wainwright maintained a Buy rating on Apellis Pharmaceuticals (APLS – Research Report), with a price target of $57.00. Douglas Tsao has given his Buy ...

With the right credentials, you can advance your career in the marketing industry. There are hundreds, if not thousands, of certifications for marketing professionals. We compiled this guide of ...

Zealand Pharma has embarked on a mission to develop the next ... (Iowa Public Media) In this podcast, George Griffith, EVP of omnichannel marketing at Relevate Health, and Sam Glassenberg, founder and ...

Essa Pharma said it is exploring “strategic options” as it ... (MarketWatch) In this podcast, George Griffith, EVP of omnichannel marketing at Relevate Health, and Sam Glassenberg, founder and CEO of ...

8/8/2023 Mission Plastics Inc. Andercraft de Mexico Mission Plastics Inc. has acquired NMH Marketing LLC and Andercraft de Mexico 9/8/2023 Rock West Composites Inc. Assets of Performance Plastics ...

Danish biotechnology company Zealand Pharma said on Thursday it expected to initiate a so-called Phase 2b trial with its obesity treatment candidate petrelintide in the fourth quarter of 2024.